Illumina Reports Third Quarter Financial Results of Fiscal Year 2018

Published on: 23 Oct, 2018

Illumina, Inc. (NASDAQ: ILMN)announced its financial results for the third quarter of fiscal year 2018.  Revenue was $853 million, a 20% increased from $714 million a year prior.  Research and development expenses increased to $159 million from $134 million a year ago.

Depreciation and amortization expenses were $46 million and capital expenditures for free cash flow purposes were $64 million during the third quarter of 2018. At the close of the quarter, the company held$3.4 billion in cash, cash equivalents and short-term investments, compared to $2.1 billion as of December 31, 2017.

“Illumina’s strong performance in the third quarter of 2018 reflected growth across our sequencing and arrays portfolios,” said Francis deSouza, President and CEO. “Sequencing system revenue of $138 million was the strongest since 2015, reflecting strong demand within our sequencing family from the NovaSeq, the most powerful and flexible sequencer ever, to the iSeq, our most accessible and easiest-to-use sequencer.”

The company expects revenue growth of 20%. 


  • 1729Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin


Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

29 Jun, 2017 3086
10 Aug, 2017 2974
24 Aug, 2017 2561
25 Aug, 2017 3195


There is no comment on this article